🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of Tylenol, asserting the companies concealed alleged dangers that the drug created to pediatric neurological development.

The lawsuit comes four weeks after President Donald Trump publicized an unsubstantiated connection between taking Tylenol - also known as paracetamol - while pregnant and autism in children.

Paxton is suing the pharmaceutical giant, which formerly manufactured the drug, the exclusive pain medication approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a declaration, he claimed they "misled consumers by profiting off of suffering and promoting medication regardless of the potential hazards."

Kenvue says there is insufficient reliable data connecting Tylenol to autism spectrum disorder.

"These companies deceived for years, intentionally threatening numerous people to boost earnings," Paxton, a Republican, stated.

The manufacturer said in a statement that it was "deeply concerned by the perpetuation of misinformation on the security of acetaminophen and the possible consequences that could have on the welfare of US mothers and children."

On its official site, Kenvue also said it had "regularly reviewed the pertinent research and there is insufficient valid information that indicates a proven link between taking acetaminophen and autism spectrum disorder."

Groups representing medical professionals and healthcare providers concur.

The leading OB-GYN organization has stated acetaminophen - the main ingredient in Tylenol - is a restricted selection for women during pregnancy to treat pain and fever, which can pose major wellness concerns if not addressed.

"In more than two decades of research on the utilization of acetaminophen in gestation, no reliable research has conclusively proven that the use of acetaminophen in any stage of gestation results in neurological conditions in young ones," the group commented.

This legal action references recent announcements from the Trump administration in arguing the drug is reportedly hazardous.

Last month, Trump caused concern from medical authorities when he told pregnant women to "fight like hell" not to use Tylenol when unwell.

Federal regulators then released a statement that doctors should think about restricting the usage of Tylenol, while also declaring that "a direct connection" between the medication and autism in minors has not been proven.

The Health Department head Kennedy, who oversees the Food and Drug Administration, had vowed in spring to initiate "a massive testing and research effort" that would identify the origin of autism in a matter of months.

But specialists advised that discovering a sole reason of autism spectrum disorder - believed by scientists to be the consequence of a complex mix of inherited and surrounding conditions - would be difficult.

Autism is a type of enduring cognitive variation and disability that impacts how persons perceive and relate to the surroundings, and is diagnosed using physician assessments.

In his court filing, the attorney general - who supports Trump who is running for federal office - claims the manufacturer and Johnson & Johnson "intentionally overlooked and sought to suppress the research" around acetaminophen and autism.

This legal action aims to force the firms "eliminate any promotional materials" that states acetaminophen is secure for expectant mothers.

The Texas lawsuit parallels the complaints of a group of guardians of children with autism and ADHD who took legal action against the makers of acetaminophen in 2022.

Judicial authorities threw out the lawsuit, declaring studies from the plaintiffs' authorities was lacking definitive proof.